http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-3087838-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc11292c0e2be7f32b201e65d49e99cd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
filingDate 2019-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74ff433760670a5ab9f0f663651dd408
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78ff1ac8249a5881f0b7da7cb7bc3dcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feb52f2bbb9c61cb045aca0d07c80d89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19b878c3a69deef1c25839d8a0f72d7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54af31e1e61e478ba150af28287dbdb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f6f88433be60d43ede3dee3ad249d89
publicationDate 2019-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-3087838-A1
titleOfInvention Minocycline for treating inflammatory skin conditions
abstract The present application relates to a method of treating an inflammatory skin condition by administering a pharmaceutical composition comprising a reduced dose of minocycline to a subject in need thereof, wherein said administration provides an effective plasma or interstitial fluid concentration of minocycline for treating the inflammatory skin condition.
priorityDate 2018-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409378928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6509979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419890815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506465
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419561490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414161244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457754985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424649925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454031468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114690
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24990553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453760858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6336229
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449646875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530952
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424508356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54671203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54684461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6419954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426116329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448718630

Total number of triples: 82.